275 related articles for article (PubMed ID: 17994443)
1. The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis.
Paydas S; Balal M; Tanriverdi K; Sertdemir Y; Baslamisli F
Ren Fail; 2007; 29(7):779-84. PubMed ID: 17994443
[TBL] [Abstract][Full Text] [Related]
2. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
[TBL] [Abstract][Full Text] [Related]
3. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
Rong ZH; Wang C; Hao J; Duan HJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):275-8. PubMed ID: 18471357
[TBL] [Abstract][Full Text] [Related]
6. Increased serum levels of vascular endothelial growth factor in human crescentic glomerulonephritis.
Nitta K; Uchida K; Kimata N; Honda K; Horita S; Hayashi T; Ishizuka T; Kobayashi H; Kawashima A; Yumura W; Nihei H
Clin Nephrol; 1999 Aug; 52(2):76-82. PubMed ID: 10480217
[TBL] [Abstract][Full Text] [Related]
7. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.
Brown FG; Nikolic-Paterson DJ; Hill PA; Isbel NM; Dowling J; Metz CM; Atkins RC
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S7-13. PubMed ID: 11792756
[TBL] [Abstract][Full Text] [Related]
8. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.
Lindenmeyer MT; Kretzler M; Boucherot A; Berra S; Yasuda Y; Henger A; Eichinger F; Gaiser S; Schmid H; Rastaldi MP; Schrier RW; Schlöndorff D; Cohen CD
J Am Soc Nephrol; 2007 Jun; 18(6):1765-76. PubMed ID: 17475821
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.
Cha DR; Kang YS; Han SY; Jee YH; Han KH; Han JY; Kim YS; Kim NH
J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of adult patients with minimal urinary abnormalities and normal renal function.
Shu KH; Ho WL; Lu YS; Cheng CH; Wu MJ; Lian JD
Clin Nephrol; 1999 Jul; 52(1):5-9. PubMed ID: 10442489
[TBL] [Abstract][Full Text] [Related]
11. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine.
Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
Nephrology (Carlton); 2008 Feb; 13(1):73-9. PubMed ID: 18199108
[TBL] [Abstract][Full Text] [Related]
12. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
Yildiz B; Kural N; Colak O; Ak I; Akcar N
Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
[TBL] [Abstract][Full Text] [Related]
13. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
[TBL] [Abstract][Full Text] [Related]
14. Is morning urinary protein/creatinine ratio a reliable estimator of 24-hour proteinuria in patients with glomerulonephritis and different levels of renal function?
Morales JV; Weber R; Wagner MB; Barros EJ
J Nephrol; 2004; 17(5):666-72. PubMed ID: 15593033
[TBL] [Abstract][Full Text] [Related]
15. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
Taira K; Hewitson TD; Kincaid-Smith P
Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
[TBL] [Abstract][Full Text] [Related]
16. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.
Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R
Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881
[TBL] [Abstract][Full Text] [Related]
17. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
[TBL] [Abstract][Full Text] [Related]
18. Prediction of subclinical renal allograft rejection by vascular endothelial growth factor in serum and urine.
Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
J Nephrol; 2008; 21(4):535-42. PubMed ID: 18651543
[TBL] [Abstract][Full Text] [Related]
19. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
Rivet J; Mourah S; Murata H; Mounier N; Pisonero H; Mongiat-Artus P; Teillac P; Calvo F; Janin A; Dosquet C
Cancer; 2008 Jan; 112(2):433-42. PubMed ID: 18041056
[TBL] [Abstract][Full Text] [Related]
20. [Serum and urinary interleukin-6 levels in patients with primary glomerulonephritis].
Hrvacević R; Topalov D; Stojanović R; Lilić D; Dimitrijević J; Maksić Dj; Marić M
Srp Arh Celok Lek; 1996; 124 Suppl 1():40-2. PubMed ID: 9102925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
